Glooko logo

Glooko Blog

Category: Real-World Data

Glooko Demonstrates Better Diabetes Management and Outcomes Through Clinical Studies

Glooko: Better Diabetes Management Infographic

At Glooko, we improve the health outcomes of people with diabetes and related chronic conditions through our personalized, intelligent, connected care platform. Our proven technologies make lives better by revolutionizing the connection between patients and healthcare providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials.

Through multiple clinical studies conducted, we’ve observed immediate and sustained improvements across multiple glycemic outcomes following remote patient monitoring (RPM). These findings show that RPM provides multiple clinical benefits and improved outcomes for people with diabetes.

Some of the highlights of our real-world data studies include:

  • Delivering Improved and Sustained Glycemic Control1,2,3

  • Use of the Glooko Mobile App Improving Glycemic Outcomes in 2 Months4

  • Declining Patient Outcomes  6-8 Weeks After Stopping Using Glooko5

Download the infographic (PDF) below for findings from our studies.

Glooko: Better Diabetes Management Infographic

1. Sheng T et al. Glycemic Improvements Following Mobile-Enabled Remote Patient Monitoring: A Randomized Control Study, ADA Scientific Sessions, June 2020. 2. Clements M, Duffee J and McCarther D. Remote patient monitoring for adults with type 2 diabetes. ADCES Research Sessions, August, 2020. 3. Sheng T, Parks L and Clements M. Remote patient monitoring in the real world: Immediate and long-term improvements in glycemic control. American Association of Diabetes Educators (AADE) Annual Meeting, Houston TX. August, 2019. 4. Offringa R et al. Digital diabetes management application improves glycemic outcomes in people with type 1 and type 2 diabetes. Journal of diabetes science and technology, 12(3), 701-708. 2018. 5. Sheng T et al. Mobile-Enabled Food Logging is Associated with Improved Glycemic Management in the Real World. Diabetes Technology Meeting (DTM), 2019. 6. Abad R et al. Use of mobile-enabled reminders feature is associated with improved behavioral and glycemic outcomes in the real world. American Diabetes Association (ADA), Scientific Sessions, 2019. 7. Babikian S et al. Deteriorating Glucose Control in Patients with Diabetes after Disengagement from a Mobile Health App. Diabetes Technology Meeting, Poster, 2020.

MKT-0084 01

Glooko’s Real-World Diabetes Patient Data Now Available on AWS Marketplace

AWS Marketplace Glooko

As of today, our real-world data repository at Glooko represents over five billion data points with 3.4 million users globally in over 7,500 clinics across 29 countries in 21 languages. The robust data points we gather that’s constantly growing each day include continuous blood glucose readings, insulin, exercise, food, medications, blood pressure, weight and patient demographics.

Our real-world data is currently being used in retrospective clinical research trials, which could potentially lead to breakthrough digital therapeutic solutions that better manage patients’ health.

And this month, Glooko joined the AWS Marketplace, Amazon’s digital catalog of commercial data products from category-leading data providers that enables individuals and companies to find, subscribe and use third-party data in the cloud.

Our leading digital health company’s de-identified patient data is now available to be applied across multiple use cases, including clinical trial design and recruitment, pre- and post-efficacy analysis of pharmaceutical interventions, population health studies and health economics and outcomes research (HEOR). Clinical researchers, data scientists and others in the life sciences space will be able to benefit greatly if they’re interested in:

  • Blood glucose statistics

  • Insulin statistics

  • Diabetes device utilization

  • Blood glucose and insulin-related statistics

  • Blood glucose readings

  • Demographics information

  • Biometrics information

  • Lifestyle data

These data points are collected by Glooko when our platform users upload and share their data in-clinic or through remote data collection tools, like the Glooko Research Mobile App, available on the App Store and Google Play Store, and the Glooko Research Uploader.

“There are so many beneficial uses of this data from patients with diabetes and related chronic conditions,” said Kevin Dougherty, vice president, life sciences at Glooko. “AWS Marketplace allows clinical researchers to easily access and utilize our existing datasets in their retrospective clinical trials to help better inform decision-making around device selection, post-marketing and HEOR.”

Some of the additional use cases for Glooko’s data include understanding how devices and wearables perform in a variety of typical practice settings and populations, as well as demonstrating the value of medicine and devices through evidence-based health economic evaluation and real-world outcomes for pricing, reimbursement and overall cost of a disease.

To access Glooko’s de-identified patient data, visit our AWS Marketplace listing and subscribe or email our team.